|
1
|
Liebner DA and Shah MH: Thyroid cancer:
Pathogenesis and targeted therapy. Ther Adv Endocrinol Metab.
2:173–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gonzalez-Gonzalez R, Bologna-Molina R,
Carreon-Burciaga RG, Gómezpalacio-Gastelum M, Molina-Frechero N and
Salazar-Rodriguez S: Papillary thyroid carcinoma: Differential
diagnosis and prognostic values of its different variants: Review
of the literature. ISRN Oncol. 2011:9159252011.PubMed/NCBI
|
|
3
|
Shi X, Liu R, Basolo F, Giannini R, Shen
X, Teng D, Guan H, Shan Z1, Teng W, Musholt TJ, et al: Differential
clinicopathological risk and prognosis of major papillary thyroid
cancer variants. J Clin Endocrinol Metab. 101:264–274. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Orang Valinezhad A, Safaralizadeh R and
Kazemzadeh-Bavili M: Mechanisms of miRNA-mediated gene regulation
from common downregulation to mRNA-specific upregulation. Int J
Genomics. 2014:9706072014.PubMed/NCBI
|
|
5
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang X, Lu X, Zhang T, Wen C, Shi M, Tang
X, Chen H, Peng C, Li H, Fang Y, et al: mir-329 restricts tumor
growth by targeting grb2 in pancreatic cancer. Oncotarget.
7:21441–21453. 2016.PubMed/NCBI
|
|
7
|
Yang H, Li Q, Zhao W, Yuan D, Zhao H and
Zhou Y: miR-329 suppresses the growth and motility of neuroblastoma
by targeting KDM1A. FEBS Lett. 588:192–197. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang P, Luo Y, Duan H, Xing S, Zhang J, Lu
D, Feng J, Yang D, Song L and Yan X: MicroRNA 329 suppresses
angiogenesis by targeting CD146. Mol Cell Biol. 33:3689–3699. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun CC, Li SJ, Zhang F, Pan JY, Wang L,
Yang CL, Xi YY and de Li J: Hsa-miR-329 exerts tumor suppressor
function through down-regulation of MET in non-small cell lung
cancer. Oncotarget. 7:21510–21526. 2016.PubMed/NCBI
|
|
10
|
Li Z, Yu X, Wang Y, Shen J, Wu WK, Liang J
and Feng F: By downregulating TIAM1 expression, microRNA-329
suppresses gastric cancer invasion and growth. Oncotarget.
6:17559–17569. 2015.PubMed/NCBI
|
|
11
|
Shiah SG, Hsiao JR, Chang WM, Chen YW, Jin
YT, Wong TY, Huang JS, Tsai ST, Hsu YM and Chou ST: Downregulated
miR329 and miR410 promote the proliferation and invasion of oral
squamous cell carcinoma by targeting Wnt-7b. Cancer Res.
74:7560–7572. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiao B, Tan L, He B, Liu Z and Xu R:
miRNA-329 targeting E2F1 inhibits cell proliferation in glioma
cells. J Transl Med. 11:1722013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li W, Liang J, Zhang Z, Lou H, Zhao L, Xu
Y and Ou R: MicroRNA-329-3p targets MAPK1 to suppress cell
proliferation, migration and invasion in cervical cancer. Oncol
Rep. 37:2743–2750. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saiselet M, Floor S, Tarabichi M, Dom
Hébrant A, van Staveren WC and Maenhaut C: Thyroid cancer cell
lines: An overview. Front Endocrinol (Lausanne).
3:1332012.PubMed/NCBI
|
|
15
|
Benad P, Rauner M, Rachner TD and Hofbauer
LC: The anti-progestin RU-486 inhibits viability of MCF-7 breast
cancer cells by suppressing WNT1. Cancer letters. 312:101–108.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stanczak A, Stec R, Bodnar L, Olszewski W,
Cichowicz M, Kozlowski W, Szczylik C, Pietrucha T, Wieczorek M and
Lamparska-Przybysz M: Prognostic significance of Wnt-1, β-catenin
and E-cadherin expression in advanced colorectal carcinoma. Pathol
Oncol Res. 17:955–963. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wieczorek M, Paczkowska A, Guzenda P,
Majorek M, Bednarek AK and Lamparska-Przybysz M: Silencing of Wnt-1
by siRNA induces apoptosis of MCF-7 human breast cancer cells.
Cancer Biol Ther. 7:268–274. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang JM, Huang FC, Kuo MH, Wang ZF, Tseng
TY, Chang LC, Yen SJ, Chang TC and Lin JJ: Inhibition of cancer
cell migration and invasion through suppressing the Wnt1-mediating
signal pathway by G-quadruplex structure stabilizers. J Biol Chem.
289:14612–14623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sasaya K, Sudo H, Maeda G, Kawashiri S and
Imai K: Concomitant loss of p120-catenin and β-catenin membrane
expression and oral carcinoma progression with E-cadherin
reduction. PLoS One. 8:e697772013. View Article : Google Scholar : PubMed/NCBI
|
